Strategic Guide for License Transfers in South Korea
Topics Covered:
In a nutshell, during the webinar, our presenter Kyeomju Nah (Senior Manager of MPR Regulatory Affairs – South Korea) discussed the following topics:
- Defining the process and importance of license transfer in the pharmaceutical industry.
- Discussing successful strategies for managing license transfers effectively.
- Highlighting Regulatory considerations and requirements during license transfers.
- Question & Answers (Q&A).
As part of our ongoing efforts, Freyr will continue to organize more webinars related to Regulatory aspects of life sciences. We are confident you would like to be a part of these sessions. If so, we would be happy to notify you about upcoming sessions.
Michael has forty (40) years of industry experience. He has worked predominantly in CMC Regulatory functions for twenty-nine (29) years with an additional eleven (11) years in other scientific development roles, including formulation development, analytical method development, and clinical trial supply, at Eli Lilly and Johnson & Johnson. His extensive experience includes managing collaborations with Regulatory partner companies, and he is currently leading a range of Regulatory programs at Freyr.
Kyeomju Nah is a Regulatory expert with approximately ten (10) years of experience, possessing deep knowledge and diverse expertise in life cycle management of existing products, as well as providing Regulatory advice for launching new products to market. An expert in Regulatory affairs within the Korean pharmaceutical industry, Kyeomju has a broad range of experience.
Host
Michael Lambell
Sr. Vice President MPR Regulatory Affairs
Presenter
Kyeomju Nah
Senior Manager MPR Regulatory Affairs – South Korea